Home
/ PolyPid
/ Competitors

PolyPid Competitors and Similar CompaniesClear all

PolyPid's competitors and similar companies include Metabolon and Adaptimmune.

	PolyPid PolyPid is a company developing a technology platform that enables a controlled and prolonged release of active pharmaceutical ingredients (API).	Metabolon Global leader in metabolomics for precision medicine, biomarker discovery, and advancing pharma & life sciences research.	Adaptimmune Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
Founding Date	Founding Date 2008	Founding Date 2000	Founding Date 2008
Type	Type Public	Type Private	Type Public
Tags	Tags Healthcare Technology biotech healthtech pharma	Tags Healthcare Technology biotech healthtech pharma	Tags Healthcare Technology biotech healthtech pharma
Locations	Locations Petah Tikva, IL HQ Summit, US	Locations Morrisville, US HQ Hallbergmoos, DE München, DE	Locations Philadelphia, US HQ Milton, GB Milton, GB Stevenage, GB
Employees	Employees 57	Employees 1911% increase	Employees 4007% decrease
Valuation ($)	Valuation ($) 23.7 m	Valuation ($) N/A	Valuation ($) 188.5 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $178m (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $70k (FY, 2024)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $178m (FY, 2024)
Net income	Net income ($34.2m) (FY, 2025)	Net income N/A	Net income ($70.8m) (FY, 2024)
Operating ⚠
Patent Applications	Patent Applications 49 (FY, 2017)	Patent Applications N/A	Patent Applications 69 (FY, 2016)
Patents Issued	Patents Issued 104 (FY, 2017)	Patents Issued N/A	Patents Issued 173 (FY, 2016)
Funding
Total funding raised	Total funding raised $ 103.8m	Total funding raised $ 95.4m	Total funding raised $ 107.5m